Novo Nordisk- Genentech and Sanofi to cut off jobs in 2018
Shots:
- Novo Nordisk lay off nearly 250 employees in US due to slow revenue growth- and they will hire undetermined numbers of new employees in new positions
- Genentech to cutback 223 job in their South San Francisco HQ due decline in sales due to biosimilar version of MabThera/Rituxan and the sales of Herceptin and MabThera have fallen by 5% & 9% resp. The company providing financial benefits- extended insurance coverage and job placement assistance to the employees
- Sanofi to cut down 670 jobs in France by 2020- additionally the company to invest 804.5M in France to raise its production sites
– Novo Nordisk- Sanofi Ref: Novo Nordisk- Genentech and Sanofi | Image: The Balance Careers
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com